119 related articles for article (PubMed ID: 8540312)
1. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer.
Miki K; Ichinose M; Kakei N; Yahagi N; Matsushima M; Tsukada S; Ishihama S; Shimizu Y; Suzuki T; Kurokawa K
Adv Exp Med Biol; 1995; 362():139-43. PubMed ID: 8540312
[No Abstract] [Full Text] [Related]
2. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
[No Abstract] [Full Text] [Related]
3. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
4. The association of smoking and drinking habits with serum pepsinogens.
Kikuchi S; Inaba Y; Wada O; Miki K; Tenjin H; Kaneko E; Mizukoshi H
Int J Epidemiol; 1995 Apr; 24(2):346-53. PubMed ID: 7635595
[TBL] [Abstract][Full Text] [Related]
5. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
7. A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.
Wu MS; Lee WC; Lin JT; Wang HP; Wang TH; Chen CJ
Anticancer Res; 1995; 15(6B):2739-43. PubMed ID: 8669856
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy.
Matsushima M; Miki K; Ichinose M; Kakei N; Yahagi N; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():131-7. PubMed ID: 8540311
[No Abstract] [Full Text] [Related]
9. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method.
Shimizu Y; Kakei N; Wada T; Yahagi N; Kido M; Ishihama S; Tsukada S; Matsushima M; Ichinose M; Miki K
Adv Exp Med Biol; 1995; 362():149-54. PubMed ID: 8540314
[No Abstract] [Full Text] [Related]
10. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
Miki K; Ichinose M; Ishikawa KB; Yahagi N; Matsushima M; Kakei N; Tsukada S; Kido M; Ishihama S; Shimizu Y
Jpn J Cancer Res; 1993 Oct; 84(10):1086-90. PubMed ID: 8226283
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
Tomooka Y
Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216
[No Abstract] [Full Text] [Related]
12. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
13. [Significance of pepsinogen analysis in clinical tests].
Miki K
Nihon Rinsho; 1989 Dec; 48 Suppl():324-6. PubMed ID: 2621894
[No Abstract] [Full Text] [Related]
14. Radioimmunoassay of serum pepsinogen in relation to gastric (pars oesophagea) ulceration in swine herds.
Nappert G; Vrins A; Beauregard M; Vermette L; Larivière N
Can J Vet Res; 1990 Jun; 54(3):390-3. PubMed ID: 2379118
[TBL] [Abstract][Full Text] [Related]
15. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
17. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
Miki K
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
[No Abstract] [Full Text] [Related]
18. [Chief cell mass in gastric ulcer: cyto-secretory correlations].
Perasso A; Testino G
Minerva Gastroenterol Dietol; 1992; 38(2):95-9. PubMed ID: 1391149
[TBL] [Abstract][Full Text] [Related]
19. Serum pepsinogen and gastric cancer screening.
Mukoubayashi C; Yanaoka K; Ohata H; Arii K; Tamai H; Oka M; Ichinose M
Intern Med; 2007; 46(6):261-6. PubMed ID: 17379991
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of serum pepsinogen and progastricsin in man.
Axelsson CK
Scand J Clin Lab Invest Suppl; 1992; 210():81-96. PubMed ID: 1455183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
